During the past decade, Centrum Medyczne Oporow conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 17 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 16 clinical trials were completed. i.e. 55.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Oporow" #1 sponsor was "Pfizer" with 11 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Galapagos NV" with 5 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Oporow" #1 collaborator was "Galapagos NV" with 4 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Excelya" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Oporow" are "Ulcerative Colitis" (10 trials), "Crohn's Disease" (4 trials), "Rheumatoid Arthritis" (3 trials), "Dermatitis, Atopic" (2 trials) and "Diffuse Cutaneous Systemic Sclerosis" (2 trials). Many other conditions were trialed in "Centrum Medyczne Oporow" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Oporow" are "Drug" (42 trials), "Other" (7 trials), "Biological" (4 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Filgotinib" (9 trials), "BMS-986165" (4 trials), "Etrasimod" (4 trials) and "Placebo to match filgotinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Oporow" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Medyczne Oporow". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Centrum Medyczne Oporow, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Oporow, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".